These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 12965986)
1. Guiding lights for antihypertensive treatment in patients with nondiabetic chronic renal disease: proteinuria and blood pressure levels? Mulrow CD; Townsend RR Ann Intern Med; 2003 Aug; 139(4):296-8. PubMed ID: 12965986 [No Abstract] [Full Text] [Related]
2. Summaries for patients. Blood pressure and urine protein levels with the least risk for worsening kidney disease. Ann Intern Med; 2003 Aug; 139(4):I36. PubMed ID: 12965997 [No Abstract] [Full Text] [Related]
3. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Jafar TH; Stark PC; Schmid CH; Landa M; Maschio G; de Jong PE; de Zeeuw D; Shahinfar S; Toto R; Levey AS; Ann Intern Med; 2003 Aug; 139(4):244-52. PubMed ID: 12965979 [TBL] [Abstract][Full Text] [Related]
4. Preventing renal disease progression: is it the drug or the blood pressure reduction, or both? Weir MR Curr Hypertens Rep; 2000 Dec; 2(6):497-9. PubMed ID: 11062593 [No Abstract] [Full Text] [Related]
7. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial. Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091 [TBL] [Abstract][Full Text] [Related]
8. Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases. Seeman T; Dusek J; Vondrák K; Flögelová H; Geier P; Janda J Am J Hypertens; 2004 May; 17(5 Pt 1):415-20. PubMed ID: 15110900 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Jafar TH; Schmid CH; Landa M; Giatras I; Toto R; Remuzzi G; Maschio G; Brenner BM; Kamper A; Zucchelli P; Becker G; Himmelmann A; Bannister K; Landais P; Shahinfar S; de Jong PE; de Zeeuw D; Lau J; Levey AS Ann Intern Med; 2001 Jul; 135(2):73-87. PubMed ID: 11453706 [TBL] [Abstract][Full Text] [Related]
10. Summaries for patients. Using a type of blood pressure medicine, angiotensin-converting enzyme inhibitors, to prevent worsening of kidney disease unrelated to diabetes. ACE Inhibition in Progressive Renal Disease Study Group Ann Intern Med; 2001 Jul; 135(2):S-21. PubMed ID: 11463005 [No Abstract] [Full Text] [Related]
11. Summaries for patients. A low blood pressure target prevented kidney failure in patients with chronic kidney disease. Ann Intern Med; 2005 Mar; 142(5):I42. PubMed ID: 15738448 [No Abstract] [Full Text] [Related]
12. Introduction: nature of microalbuminuria, proteinuria, and progressive renal disease. Mogensen CE J Diabetes Complications; 1995; 9(1):2-6. PubMed ID: 7734738 [No Abstract] [Full Text] [Related]
13. Antihypertensive therapy in the presence of proteinuria. Sarafidis PA; Khosla N; Bakris GL Am J Kidney Dis; 2007 Jan; 49(1):12-26. PubMed ID: 17185142 [TBL] [Abstract][Full Text] [Related]
14. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Sarnak MJ; Greene T; Wang X; Beck G; Kusek JW; Collins AJ; Levey AS Ann Intern Med; 2005 Mar; 142(5):342-51. PubMed ID: 15738453 [TBL] [Abstract][Full Text] [Related]
15. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy. Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375 [TBL] [Abstract][Full Text] [Related]
16. Hypertension and progression of renal disease. Maschio G; Oldrizzi L; Marcantoni C; Rugiu C J Nephrol; 2000; 13(3):225-7. PubMed ID: 10928300 [TBL] [Abstract][Full Text] [Related]